{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-23-000160","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.788921+00:00","generated_at":"2026-06-08T06:18:46.076095+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Kiora Pharmaceuticals furnishes updated investor presentation with no specific new facts disclosed","bullets":["Filed under Item 7.01 and 9.01; presentation provided as Exhibit 99.1.","No financial guidance, operational milestones, or clinical data disclosed in the filing.","The presentation may be used for investor meetings; content not detailed in this 8-K.","Ticker: KPRX; sentiment neutral due to lack of material new information."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-23-000160","json":"https://secwatch.observer/filing/0001372514-23-000160.json","markdown":"https://secwatch.observer/filing/0001372514-23-000160.md","text":"https://secwatch.observer/filing/0001372514-23-000160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/0001372514-23-000160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/kprx-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:18:46.076095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}